Zobrazit všechny články

Akcie AstraZeneca

21.7.2013 Tomáš Baťa (přečteno 3794x)
Akcie AstraZeneca

AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments for illnesses, such as its antibiotic, Merrem/Meronem and Losec/Prilosec for acid related diseases. AstraZeneca’s products include Crestor, Atacand,Seloken/Toprol-XL, Plendil, Onglyza, Zestril, Symbicort and Zoladex. The Company owns and operates a range of research and development (R&D), production and marketing facilities worldwide. AstraZeneca operates in over 100 countries, including China, Mexico, Brazil and Russia. In June 2013, the Company acquired Pearl Therapeutics. In July 2013, AstraZeneca PLC has sold its toxicological laboratory in Gartuna to Acturum. On July 18, 2013, the Company acquired Omthera Pharmaceuticals.

Graf a data

Tipy pro investory: Naučte se základy opčního obchodování

Komentáře k článku